HD homozygote individuals with two mutant HD genes, and therefore no wild-type huntingtin, develop the characteristic movement disorder with timing comparable to that seen in typical HD mutation heterozygote individuals, indicating the absence of a strong dosage effect. This evidence concerns the gene HTT and Huntington disease.